Text or call a human:Text (808) 600-9260Call
CorporateVentureCapital.com

Roche Venture Fund

Profile, fund size and portfolio

Parent F. Hoffmann-La RocheHQ Basel, SwitzerlandFounded 2002

Roche Venture Fund is the corporate venture arm of F. Hoffmann-La Roche, a pharmaceutical and biotech company. It was founded in 2002 and is based in Basel, Switzerland. It invests at the Series A stage. Sectors it names: biotech and life sciences, medical devices, healthcare and digital health.

Evergreen allocationS1
CHF 750M
Companies backedS3
30+
IPOsS3
32

Every figure links to its source

Snapshot

Investment stage: Series A to Series A
Data behind this graphic
Data behind this graphic
ItemValue
Stage rangeSeries A to Series A
SectorsBiotech and life sciences, Medical devices, Healthcare and digital health
GeographyNorth America, Europe
OfficesBasel, Switzerland, South San Francisco, United States

Sources: S4 Roche Venture Fund investing; S1 Roche Venture Fund home (fast facts).

Graphic 1 of 3

Investment stage: Series A to Series A

Sources: S4 Roche Venture Fund investing; S1 Roche Venture Fund home (fast facts).

Download:Report a correction
Investments closed by outcome
Data behind this graphic
Data behind this graphic
ItemCompaniesShare
Exited6672.5%
Active2527.5%

Status as the firm tags it

Sources: S3 Roche Venture Fund portfolio (current and historic).

Graphic 2 of 3

Investments closed by outcome

Sources: S3 Roche Venture Fund portfolio (current and historic).

Download:Report a correction
Scale and capital allocated
Data behind this graphic
Data behind this graphic
MeasureValueUnitKindSource
Headline sizeCHF 750MEvergreen allocationStated by the firm or its parentS1
Companies backed30+companiesStated by the firmS3
IPOs32IPOsStated by the firmS3
Companies on the firm's portfolio page91companiesCounted from the firm's own listS3

Sources: S1 Roche Venture Fund home (fast facts); S3 Roche Venture Fund portfolio (current and historic).

Graphic 3 of 3

Scale and capital allocated

Firms and databases count companies, rounds and investments differently.

Sources: S1 Roche Venture Fund home (fast facts); S3 Roche Venture Fund portfolio (current and historic).

Download:Report a correction

Where it invests and who leads it

Geography

Headquarters
Basel, Switzerland
Offices

Investment regionsS4S1

LeadersS2

Roche Venture Fund on LinkedIn

Key facts

FactValueStatusSource
Parent companyF. Hoffmann-La RocheSingle sourceS1
Parent industryPharmaceuticals and biotechSingle sourceS1
Founded2002Reported by aVenture: Roche Venture Fund research profile (launch yearS5
HeadquartersBasel, SwitzerlandSingle sourceS1
StatusActiveSingle sourceS1
Capital sourceParent company onlySingle sourceS1
Headline sizeCHF 750M (Evergreen allocation)Single sourceS1
Companies backed30+Single sourceS3
Exits66 total, 32 IPOsSingle sourceS3
People on the team page5Single sourceS2
StagesSeries ASingle sourceS4

Notable outcomes

IPOs and acquisitions of portfolio companies. Price shown only where published.

CompanyTypeAcquirer or exchangeSource
AfferentAcquisitionMerckS3
AliosAcquisitionJohnson+JohnsonS3
AmbitAcquisitionDaiichi SankyoS3
AmbrxAcquisitionWuxiS3
ArtusAcquisitionQiagenS3
AvexisAcquisitionNovartisS3
BioFireAcquisitionbioMérieuxS3
BioXellAcquisitionCosmoS3
Care InnovationsAcquisitionPRA Health SciencesS3
CGIAcquisitionGileadS3
DVSAcquisitionFluidigmS3
EnvoyAcquisitionTakedaS3
Fabric GenomicsAcquisitionGeneDxS3
FlatironAcquisitionRocheS3
Foundation MedicineAcquisitionRocheS3
Good TherapeuticsAcquisitionRocheS3
HistoRxAcquisitionGenoptixS3
LeukositeAcquisitionMillenniumS3
Lino BiotechAcquisitionMiltenyi BiotechS3
LTIAcquisitionBialS3

Portfolio

The firm's portfolio page lists 91 companies: 66 exited, 25 active.S3

The firm also states 30+ companies backed. The page list and the stated total measure different things.S3

Companies by status on the firm's list. Status as the firm tags itS3
TagCompaniesShare
Exited6672.5%
Active2527.5%

Shared portfolio with other corporate VCs

13 companies on the Roche Venture Fund portfolio page also appear on the portfolio page of at least one other firm in this directory. Matched by company website, or by name where no website is published.

FirmSharedCompanies in common
GV5EpiBiologics, Freenome, 23andMe, Foundation Medicine, IDEAYA Biosciences
Novartis Venture Fund3EpiBiologics, SpliceBio, Vivet Therapeutics
Pfizer Ventures2Mission Therapeutics, Second Genome
JJDC1EpiBiologics
Taiho Ventures1EpiBiologics
Intermountain Ventures1Freenome
Kaiser Permanente Ventures1Freenome
Quest Diagnostics1Freenome
Sanofi Ventures1SpliceBio
UCB Ventures1SpliceBio
Goodyear Ventures1Envoy
R/GA Ventures1Envoy

Companies backed by the most corporate VCs

Every company on the Roche Venture Fund list

91 companies, as listed on the firm's own website: 66 exited, 25 active.S3 Read the firm's list.

Exited 66

  • 23andMe
  • Addex
  • Afferent
  • Aileron
  • Alios
  • Allakos
  • Ambit
  • Ambrx
  • Anadys
  • Artus
  • Avexis
  • BioFire
  • BioXell
  • Black Diamond Therapeutics
  • Blueprint Medicines
  • C4 Therapeutics
  • Caliper
  • Care Innovations
  • Centessa
  • CGI
  • Complete Genomics
  • Conatus
  • Corvus Pharmaceuticals
  • Curetis
  • CV Therapeutics
  • CytomX
  • deCode
  • DVS
  • Envoy
  • Fabric Genomics
  • Fibrogen
  • Flatiron
  • Foundation Medicine
  • Good Therapeutics
  • Halozyme Therapeutics
  • HistoRx
  • Horizon Discovery
  • IDEAYA Biosciences
  • Jasper Therapeutics
  • Leukosite
  • Lino Biotech
  • LTI
  • Lumos Pharma
  • Maculogix
  • Memory
  • Miikana
  • Miragen
  • MySugr
  • Nimble Therapeutics
  • Pandion
  • Pharmasset
  • Protein Design Labs
  • Purigen
  • Second Genome
  • Senseonics
  • Sequana
  • Stratos Genomics
  • Syrrx
  • Taimed
  • Tango Therapeutics
  • TiGenix
  • Tripath
  • Vaxcyte
  • Viewics
  • Xenon
  • Zikanii

Active 25

  • Aligos
  • Bonum Therapeutics
  • Civi Biopharma
  • Cour
  • DiogenX
  • Enliven Therapeutics
  • Enthera
  • Entrada
  • EpiBiologics
  • Forcefield Therapeutics
  • Freenome
  • Glycoera
  • Kumquat Biosciences
  • Merge Therapeutics
  • Minoryx
  • Mironid
  • Mission Therapeutics
  • NMD Pharma
  • Noema Pharma
  • Receptive Bio
  • River3Renal
  • Sarepta Therapeutics
  • SpliceBio
  • Tempest Therapeutics
  • Vivet Therapeutics

For founders

ItemWhat the firm saysSource
StagesSeries AS4
Check size, Series ACHF 3M to CHF 10MS4

Fund vehicles

VehicleSizeSource
Roche Venture Fund (evergreen)CHF 750MS1

History

  1. Roche Venture Fund operates independently from 2002 (aVenture profile).S5

Official pages

Read the firm's own pages for current information.

  • Website www.roche.com/venturefund
  • Portfolio www.roche.com/venturefund/venturefund-portfolio

Sources

  1. S1Roche Venture Fund home (fast facts)Firm
  2. S2Roche Venture Fund teamFirm
  3. S3Roche Venture Fund portfolio (current and historic)Firm
  4. S4Roche Venture Fund investingFirm
  5. S5aVenture: Roche Venture Fund research profile (launch year, earlier CHF 500M figure)Third-party report

Disclaimer and corrections

Not affiliated. This page is not affiliated with, endorsed by or sponsored by Roche Venture Fund or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.

Spotted a mistake? Report a correction.